Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Nove Mesto – page 24

368 clinical trials in Nove Mesto, Slovakia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Nove Mesto at a glance
368
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

368 trials in Nove Mesto

Open in trial search

Colorectal cancer+6

Not recruiting

Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:INCB099280
  • Sponsor:Incyte Corp.

Study on the Effectiveness of Apalutamide in Men with Castration-Resistant Prostate Cancer

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:Aragon Pharmaceuticals Inc.

Cardiac failure

Not recruiting

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Azilsartan Medoxomil
  • Sponsor:Novartis Pharma AG

Schizophrenia

Not recruiting

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Valbenazine Ditosylate
  • Sponsor:Neurocrine Biosciences Inc.

Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB

Alopecia areata

Not recruiting

Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

Investigational
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Asthma

Not recruiting

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:MRNA-4157
  • Sponsor:Merck Sharp & Dohme LLC

Hypophosphatasia

Not recruiting

Study on ALXN1850 for Adolescents and Adults with Hypophosphatasia Not Previously Treated with Asfotase Alfa

Investigational
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:ALXN1850
  • Sponsor:Alexion Pharmaceuticals Inc.

Cachexia

Not recruiting

Study of ponsegromab for patients with cancer cachexia and elevated GDF-15 levels

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Ponsegromab
  • Sponsor:Pfizer Inc.

Hepatic cirrhosis

Not recruiting

Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:AstraZeneca AB

Multiple sclerosis

Not recruiting

Study on the Safety and Effectiveness of Fingolimod and Interferon Beta-1a in Children with Multiple Sclerosis

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:0–17 years
  • Substances:Fingolimod
  • Sponsor:Novartis Pharma AG

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Nove Mesto

What the registry says about research in the country

01 Cardiovascular Diseases

Clinical trial activity in Nove Mesto includes research in cardiovascular diseases, with a focus on atrial fibrillation and stable angina pectoris. These studies are designed to assess new treatment options and confirm whether emerging therapies can better prevent complications or relieve symptoms.

  • Prevention of cardioembolic events in atrial fibrillation
  • Evaluation of anti-anginal effects in stable angina pectoris
  • Testing treatment effectiveness for ongoing heart-related conditions

Overall, this area reflects active work aimed at improving both protection from serious cardiovascular events and day-to-day symptom control.

02 Digestive System and Liver Disorders

Another important research focus is digestive system diseases, especially studies involving hepatic impairment and moderate or severe hepatic impairment. These trials look at how liver problems may affect the safety and behavior of investigational therapies, helping define whether treatments can be used more effectively in people with liver disease.

  • Study of liver-related effects on treatment use
  • Research involving hepatic impairment and liver problems
  • Assessment of safety and tolerability in patients with compromised liver function

This area supports safer prescribing decisions and better understanding of how new therapies perform in patients with liver conditions.

03 Nutritional and Metabolic Diseases

Trials in nutritional and metabolic diseases are centered on hypertriglyceridemia and severe hypertriglyceridemia, reflecting a clear effort to improve management of abnormal lipid levels. The research is mainly aimed at testing whether new therapies can lower triglycerides and support better metabolic health.

  • Reduction of fasting serum triglyceride levels
  • Studies in hypertriglyceridemia and severe hypertriglyceridemia
  • Evaluation of treatment effectiveness for lipid-related disorders

These studies are relevant for patients at risk of complications linked to elevated triglycerides and broader metabolic imbalance.

04 Unspecified Therapeutic Area

Some studies in the city span broader or not fully specified categories, but they still contribute to a diverse clinical research environment. The overall pattern suggests work across multiple medical fields, with a strong emphasis on evaluating new therapies, confirming benefits, and improving how existing conditions are managed.

  • Broad clinical research across multiple disease areas
  • Testing the value of emerging treatment approaches
  • Supporting better disease management through clinical evaluation

With several recruiting sites active, the local trial landscape in Slovakia remains focused on practical questions that matter for patient care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.